D
Lineage Cell Therapeutics, Inc. LCTX
$1.25 $0.086.84% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -69.14% 31.49% 13.39% 12.81% -9.82%
Total Depreciation and Amortization -6.14% -14.08% -11.99% -8.26% -5.52%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 451.74% -71.09% 21.17% -6.77% 52.01%
Change in Net Operating Assets -174.73% -50.18% 18.86% 43.89% 74.23%
Cash from Operations -2.47% 3.95% 19.16% 26.21% 29.65%
Capital Expenditure -84.91% -19.08% 16.17% 48.68% 55.46%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 168.58% -99.18% -103.70% -84.18% 131.27%
Cash from Investing 177.35% -101.18% -104.97% -84.82% 126.53%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -5.77% -1.85% 0.00% -6.00% -13.04%
Issuance of Common Stock 80.51% 31.43% 436.15% 106.94% 145.06%
Repurchase of Common Stock 63.96% 93.24% 90.25% -500.00% -500.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -393.10% -- -- 194.76% -73.99%
Cash from Financing 77.40% 31.49% 458.26% 115.16% 122.19%
Foreign Exchange rate Adjustments 231.02% 55.45% 62.00% 126.56% 76.11%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 394.65% -84.98% -56.93% -155.11% 88.41%